title: Novel prognostic tissue markers in congestive heart failure.
abstract: Heart failure is a relatively common disorder associated with high morbidity, mortality, and economic burden. Better tools to predict outcomes for patients with heart failure could allow for better decision making concerning patient treatment and management and better utilization of health care resources. Endomyocardial biopsy offers a mechanism to pathologically diagnose specific diseases in patients with heart failure, but such biopsies can often be negative, with no specific diagnostic information. Novel tissue markers in endomyocardial biopsies have been identified that may be useful in assessing prognosis in heart failure patients. Such tissue markers include ubiquitin, Gremlin-1, cyclophilin A, and heterogeneous nuclear ribonucleoprotein C. In some cases, tissue markers have been found to be independent of and even superior to clinical indices and serum markers in predicting prognosis for heart failure patients. In some cases, these novel tissue markers appear to offer prognostic information even in the setting of an otherwise negative endomyocardial biopsy.
authors.affiliation: Center for Systems Biology, Massachusetts General Hospital and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. Electronic address: jrstone@partners.org.
authors.forename: James R
authors.initials: JR
authors.lastname: Stone
mesh_terms: D015415:Biomarkers / Q000032:analysis*; D006333:Heart Failure; D006801:Humans; D011379:Prognosis
chemical_list: D015415:Biomarkers
keywords: Apoptosis; Cyclophilin A; Gremlin-1; Heterogeneous nuclear ribonucleoprotein C; Proliferation; Ubiquitin